The estimated Net Worth of Oliver Schacht is at least $606 Thousand dollars as of 31 March 2023. Dr Schacht owns over 12,469 units of Opgen Inc stock worth over $39,832 and over the last 4 years he sold OPGN stock worth over $0. In addition, he makes $565,869 as CEO and Pres & Director at Opgen Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Dr Schacht OPGN stock SEC Form 4 insiders trading
Dr has made over 6 trades of the Opgen Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 12,469 units of OPGN stock worth $25,187 on 31 March 2023.
The largest trade he's ever made was exercising 38,750 units of Opgen Inc stock on 2 March 2022 worth over $78,275. On average, Dr trades about 10,004 units every 73 days since 2020. As of 31 March 2023 he still owns at least 19,719 units of Opgen Inc stock.
You can see the complete history of Dr Schacht stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Dr. Oliver Schacht biography
Dr. Oliver Schacht is the CEO, Pres & Director at Opgen Inc.
What is the salary of Dr Schacht?
As the CEO and Pres & Director of Opgen Inc, the total compensation of Dr Schacht at Opgen Inc is $565,869. There are no executives at Opgen Inc getting paid more.
How old is Dr Schacht?
Dr Schacht is 49, he's been the CEO and Pres & Director of Opgen Inc since . There are 7 older and no younger executives at Opgen Inc. The oldest executive at Opgen Inc is Dr. G. Terrance Walker Ph.D., 62, who is the Sr. VP of R&D.
What's Dr Schacht's mailing address?
Oliver's mailing address filed with the SEC is C/O OPGEN, INC. 9717 KEY WEST AVE., SUITE 100, ROCKVILLE, MD, 20850.
Insiders trading at Opgen Inc
Over the last 9 years, insiders at Opgen Inc have traded over $12,018 worth of Opgen Inc stock and bought 4,331,782 units worth $1,198,700 . The most active insiders traders include Evan/ Fa Jones, Capital, Llcjones Evan/ Fa ..., and Capital, Llc J Ven. On average, Opgen Inc executives and independent directors trade stock every 78 days with the average trade being worth of $280,277. The most recent stock trade was executed by Johannes Bacher on 31 March 2023, trading 6,434 units of OPGN stock currently worth $12,997.
What does Opgen Inc do?
opgen, inc. (nasdaq: opgn) is harnessing the power of informatics and genomic analysis to provide complete solutions for infection prevention and treatment. using our large and ever-growing acuitas lighthouse® knowledgebase of pathogens from around the world, we are developing disruptive technologies aimed to shift the paradigm for managing infectious diseases. today, through our clia-certified clinical laboratory services, we provide rapid detection and analysis of antibiotic resistance and high resolution microbial sequence analysis. our fda-cleared, ivd products rapidly identify pathogens in positive blood cultures.
What does Opgen Inc's logo look like?
Complete history of Dr Schacht stock trades at Opgen Inc
Opgen Inc executives and stock owners
Opgen Inc executives and other stock owners filed with the SEC include:
-
Dr. Oliver Schacht Ph.D.,
CEO, Pres & Director -
Dr. Oliver Schacht,
CEO, Pres & Director -
Timothy C. Dec,
CFO & Corp. Sec. -
Johannes Bacher,
Chief Operating Officer -
Dr. Arne Materna,
MD & CEO of Ares Genetics GmbH -
Derek Joesting,
Sr. VP of US Sales -
Albert Weber,
Chief Financial Officer -
Dr. Achim Plum,
Special Advisor of Ares Genetics GmbH -
Dr. Andreas Posch,
Special Advisor of Ares Genetics GmbH -
Christopher D. Emery,
Chief Commercial Officer for the Americas -
Dr. G. Terrance Walker Ph.D.,
Sr. VP of R&D -
Faranak Atrzadeh,
Chief Marketing & Scientific Affairs Officer -
Michael Farmer,
VP of Marketing -
Vadim Sapiro,
Chief Information Officer -
& Co., Inc.Merck Sharp & Do...,
-
Laurence Mc Carthy,
Director -
Capital, Llc J Ven,
10% owner -
Misti Ushio,
Director -
Timothy J.R. Harris,
Director -
Kevin Krenitsky,
President -
Brian G Atwood,
Director -
Timothy C Dec,
Chief Financial Officer -
Tina Susan Nova,
Director -
Evan/ Fa Jones,
Director -
Capital, Llcjones Evan/ Fa ...,
Chairman and CEOChief Executive Officer -
Vadim M. Sapiro,
Chief Information Officer -
R Don Elsey,
Director -
Matthew Charles Mc Murdo,
Director -
David Natan,
Director -
Avraham Ben Tzvi,
Director -
Mario Crovetto,
Director -
Johannes Bacher,
Chief Operating Officer -
Prabhavathi Fernandes,
Director -
William E. Rhodes,
Director -
Oliver Schacht,
Chief Executive Officer -
Albert Weber,
Chief Finanical Officer -
Yvonne Schlaeppi,
Director -
David E. Lazar,
Chief Executive Officer